Tag Archive for: Cancer

ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A

Co-founded with renowned immunologist Professor Caetano Reis e Sousa of the Francis Crick Institute First UK-based ATP portfolio company NEW YORK and LONDON, December 7, 2021—ATP (Apple Tree Partners), a leader in life sciences venture capital, today announced the launch of Adendra Therapeutics Ltd. (“Adendra”), a company that will discover and develop treatments for cancers and autoimmune diseases […]

Joint Development Agreement with 4basebio PLC for novel CAR T-cell production methods

Leucid Bio: Joint Development Agreement with 4basebio PLC for novel CAR T-cell production methods 4basebio PLC (AIM: 4BB), the specialist life sciences group focused on exploiting intellectual property in the field of cell and gene therapies and DNA vaccines, is pleased to announce a Joint Development Agreement (“JDA”) between its wholly owned subsidiary 4basebio Discovery […]

Natural Killer Cells from Universal Donors

Has Kiadis Found Immunotherapy’s Killer App? In Amsterdam, there has just been a glimpse of the future of cellular medicine.

A Case Study by Masters Pharma

With World Cancer Day in mind this week, we want to put the spotlight on our fantastic client Masters Pharma.

ISA Pharmaceuticals B.V. receives EUR 20m loan from European Investment Bank

The European Investment Bank and ISA Pharmaceuticals have signed a EUR 20 million loan agreement to support the development of ISA’s therapy for cancers caused by the Human Papillomavirus type 16 (HPV16). Read more